Goat anti-OPRK1 Antibody |
| Principle Name | OPRK1 |
| Official Symbol | OPRK1 |
| All Name and Symbols | OPRK1; opioid receptor, kappa 1; KOR; OPRK; Opiate receptor, kappa-1; kappa opioid receptor |
| Accession Number(s) | NP_000903.2 |
| Peptide Sequence | PAYLRDIDGMNKP, is from C Terminus |
| Human Gene ID(s) | 4986 |
| Non-Human GeneID(s) | 18387 (mouse); 29335 (rat); |
| Important Comments | |
| Purification | Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
| Supplied As | lyophilized powder of 50ug or 100ug IgG; Reconsititute IgG with 100ul or 200ul sterile DI Water and final product will be formulated as 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20°C. Minimize freezing and thawing. |
| Applications | Pep ELISA, WB |
| Tested Species | Human |
| Peptide ELISA | antibody detection limit dilution 1 to 16000. |
| Western Blot | Approx 45kDa band observed in Human Brain (Cerebral Cortex) lysates (calculated MW of 42.6kDa according to NP_000903.2). Recommended concentration |
| Reference(s) | Li JG, Chen C, Liu-Chen LY. N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway. Biochemistry. 2007 Sep 25;46(38) |
